Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

BLCO


Fundamental

Company: Bausch + Lomb Corp
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: Canada
Exchange: NYSE
Index: -
P/E: -
EPS (ttm): -0.86
Insider Own: 89.25%
Shs Outstand: 354.09M
Perf Week: 1.80%
Market Cap: 6.02B
Forward P/E: 21.11
EPS next Y: 0.81
Insider Trans: 0.00%
Shs Float: 38.07M
Perf Month: -2.30%
Enterprise Value: 10.71B
PEG: 1.05
EPS next Q: 0.36
Inst Own: 10.20%
Short Float: 9.68%
Perf Quarter: 8.07%
Income: -305.00M
P/S: 1.21
EPS this Y: -15.62%
Inst Trans: 0.14%
Short Ratio: 9.93
Perf Half Y: 23.19%
Sales: 4.98B
P/B: 0.94
EPS next Y Percentage: 51.47%
ROA: -2.23%
Short Interest: 3.68M
Perf YTD: -0.47%
Book/sh: 18.16
P/C: 18.14
EPS next 5Y: 20.07%
ROE: -4.69%
52W High: 17.86 -4.82%
Perf Year: -4.23%
Cash/sh: 0.94
P/FCF: -
EPS past 3/5Y: - -
ROIC: -2.69%
52W Low: 10.45 62.68%
Perf 3Y: -2.35%
Dividend Est.: -
EV/EBITDA: 18.79
Sales past 3/5Y: 8.36% 4.87%
Gross Margin: 54.02%
Volatility W: 3.32%
Volatility M: 2.51%
Perf 5Y: -
Dividend TTM: -
EV/Sales: 2.15
EPS Y/Y TTM: 17.53%
Oper. Margin: 2.85%
ATR (14): 0.45
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 0.98
Sales Y/Y TTM: 6.23%
Profit Margin: -6.13%
RSI (14): 52.81
Recom: 2.44
Dividend Gr. 3/5Y: - -
Current Ratio: 1.51
EPS Q/Q: -799.12%
SMA20: 0.13%
Beta: 0.61
Target Price: 17.54
Payout: -
Debt/Eq: 0.77
Sales Q/Q: 7.11%
SMA50: 0.52%
Rel Volume: 0.95
Prev Close: 16.41
Employees: 13500
LT Debt/Eq: 0.77
Earnings: Feb 18 BMO
SMA200: 16.29%
Avg Volume: 370.99K
Price: 17.00
IPO: May 06, 2022
Option/Short: Yes / Yes
EPS/Sales Surpr.: 12.85% 0.27%
Trades:
Volume: 352,046
Change: 3.60%

Technical:


Latest News:

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Bausch + Lomb ... very bullish
AMGN BLCO

Summary: Analysts have expressed bullish sentiments on Amgen (AMGN) and Bausch + Lomb Corporation (BLCO) in the Healthcare sector. Wells Fargo analyst maintained a Buy rating on both companies, setting price targets of $320.00 for Amgen and $23.00 for BLCO. The consensus ratings for these stocks suggest potential upsides of 14.1% and 31.5% respectively.

Full article
2024-04-24T20:31:52Z